Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Applications
ELISA
Western Blot
3D Cell Culture
PCR
Quantitative PCR
Digital PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
Application Notes
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Protein Biochemistry
Chemicals and Reagents
CB-5083
CB-5083 from Cayman Chemical
Be the first to write a review!
Citations:
(14)
Supplier Page
Supplier Page from
Cayman Chemical for
CB-5083
Request Info
Description
An orally bioavailable inhibitor of p97 (IC50 = 11 nM); causes accumulation of poly-ubiquitinated proteins, retention of ERAD substrates, and activation of the apoptotic arm of the unfolded protein response
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
CB-5083
Company
Cayman Chemical
Price
$267.00
Supplier Page
View Company Product Page
Catalog Number
19311
Format
A crystalline solid
Research Area
Apoptosis, Cancer, Cell Biology, Cell Death, Endomembrane System & Vesicular Trafficking, ER Protein Folding, Proteolysis, Ubiquitin/Proteasome System
Molecular Weight
413.5
Quantity
10 mg
Purity
≥95%
Type
Inhibitors
Origin
USA
Formula
C24H23N5O2
Storage
-20
Add to Compare List
Cayman Chemical
Cayman Chemical Company 1180 East Ellsworth Road
Ann Arbor
,
Michigan
48108
United States
Phone
: (800) 364-9897
(734) 971-3640
Company Profile
Website:
http://www.caymanchem.com/
Citations (14)
(1)
Identification of ERAD-dependent degrons for the endoplasmic reticulum lumen
eLife
November 12, 2024
Rachel Sharninghausen, Jiwon Hwang, Devon D Dennison, Ryan D Baldridge
DMSO, treated with 50 nM bortezomib (APExBIO, A2614), or treated with 1 μM CB5083 (
Cayman Chemicals
,
19311
) for the indicated time periods prior to collection. For combination treatments, cells were pretreated
(2)
Identification of ERAD-dependent degrons for the endoplasmic reticulum lumen
Elife
November 12, 2024
Rachel Sharninghausen, Jiwon Hwang, Devon D Dennison, Ryan D Baldridge
DMSO, treated with 50 nM bortezomib (APExBIO, A2614), or treated with 1 μM CB5083 (
Cayman Chemicals
,
19311
) for the indicated time periods prior to collection. For combination treatments, cells were pretreated
(3)
VCP activator reverses nuclear proteostasis defects and enhances TDP-43 aggregate clearance in multisystem proteinopathy models
The Journal of clinical investigation
May 23, 2024
Phan JM, Creekmore BC, Nguyen AT, Bershadskaya DD, Darwich NF, Mann CN, Lee EB.
of MG132 and the addition of 30 μg/μL of CHX (C1988, Sigma-Aldrich) with DMSO or 2.5 μM of CB5083 (
19311
,
Cayman Chemical Company
) for 6 hours. To test efficacy of UP109, UP158, UP163, or UP12 activator in
(4)
TurboID-Based IRE1 Interactome Reveals Participants of the Endoplasmic Reticulum-Associated Protein Degradation Machinery in the Human Mast Cell Leukemia Cell Line HMC-1.2
Cells
April 25, 2024
Ahmed N, Preisinger C, Wilhelm T, Huber M.
μg/mL CHX (Sigma-Aldrich, #01810) for the indicated times.
VCP
activity was inhibited by
CB-5083
(#
19311
) or
NMS-873
(#
17674
) (1 μM; both from
Cayman
, Ann Arbor, MI, USA). 2.5. RNA Preparation and Quantitative
(5)
Early recovery of proteasome activity in cells pulse-treated with proteasome inhibitors is independent of DDI2
Elife
April 15, 2024
Ibtisam Ibtisam, Alexei F Kisselev
C-3022","Proteasome
Inhibitors
," "Chemical compound, drug",
CB-5083
,
Cayman Chemicals
,"CAS# 1542705-92-9, Cat#
19311
","p97
inhibitor
," "Chemical compound, drug",CHAPS (3-((3-cholamidopropyl) dimethylammonio)–1-propanesulfonate),Thermo
(6)
Early recovery of proteasome activity in cells pulse-treated with proteasome inhibitors is independent of DDI2
eLife
April 15, 2024
Ibtisam Ibtisam, Alexei F Kisselev
C-3022","Proteasome
Inhibitors
," "Chemical compound, drug",
CB-5083
,
Cayman Chemicals
,"CAS# 1542705-92-9, Cat#
19311
","p97
inhibitor
," "Chemical compound, drug",CHAPS (3-((3-cholamidopropyl) dimethylammonio)–1-propanesulfonate),Thermo
(7)
UBXN1 maintains ER proteostasis and represses UPR activation by modulating translation
EMBO Reports
January 2, 2024
Brittany A Ahlstedt, Rakesh Ganji, Sirisha Mukkavalli, Joao A Paulo, Steve P Gygi, Malavika Raman
Triton X-100 (97063-864) was purchased from VWR.
CB-5083
were purchased from
Cayman Chemical Company
(
19311
).
Bortezomib
(
S1013
) was purchased from
Selleckchem
. EndoH (
P0702S
) was purchased from
New England Biolabs
.
(8)
Novel VCP activator reverses multisystem proteinopathy nuclear proteostasis defects and enhances TDP-43 aggregate clearance
bioRxiv
October 9, 2023
Jessica M. Phan, Benjamin C. Creekmore, Aivi T. Nguyen, Darya D. Bershadskaya, Nabil F. Darwich, Edward B. Lee
MG132 and the addition of 30μg/μL of cycloheximide, CHX (C1988, Sigma) with DMSO or 2.5μM of CB5083 (
19311
,
Cayman Chemical Company
,Ann Arbor, MI, USA) for 6 hours. To test efficacy of UP109 activator, cells
(9)
Topological regulation of a transmembrane protein by luminal-to-cytosolic retrotranslocation of glycosylated sequence
Cell reports
April 25, 2023
Wang J, Han S, Ye J.
,
New England Biolabs
,
P0704
PNGase F
,
Promega
,
V4831
Proteinase K,Roche,RPROTK-RO
CB-5083
,
Cayman Chemical
,
19311
Doxycycline hyclate
,
Sigma-Aldrich
,D9891 ,, Critical commercial
assays
,Critical commercial
assays
,Critical
(10)
Drug resistance mechanisms create targetable proteostatic vulnerabilities in Her2+ breast cancers
PLOS ONE
December 8, 2022
Navneet Singh, Lindsey Romick-Rosendale, Miki Watanabe-Chailland, Lisa M. Privette Vinnedge, Kakajan Komurov
were incubated with lapatinib was from (
Selleck Chemicals
,
S1028
), 250nM
CB-5083
(
Cayman Chemicals
,
19311
), and 15μM guanabenz (
Tocris
, 0885).
Lapatinib
drug treatment
Lapatinib
-resistant cell lines were
(11)
Targeting non-canonical pathways as a strategy to modulate the sodium iodide symporter
Cell chemical biology
March 17, 2022
Read ML, Brookes K, Thornton CEM, Fletcher A, Nieto HR, Alshahrani M, Khan R, Borges de Souza P, Zha L, Webster JRM,
et al
.
Proteins" ,, Astemizole,Sigma-Aldrich,Cat# 2861 Carebastine,Sigma-Aldrich,Cat#
24186
CB-5083
,
Cayman Chemical
,Cat#
19311
Chloroquine Diphosphate,
Sigma-Aldrich
,Cat#
C6628
Clotrimazole
,
Sigma-Aldrich
,Cat#
C6019
DBeQ,Sigma-Aldrich,Cat#
(12)
SURF4-induced tubular ERGIC selectively expedites ER-to-Golgi transport
Developmental cell
February 28, 2022
Yan R, Chen K, Wang B, Xu K.
120299
Dithiothreitol (DTT
),
Thermo Fisher
,Cat#
R0861
MG132,
Tocris
,Cat#
1748
CB-5083
,
Cayman Chemical
,Cat#
19311
Thapsigargin
,
Invitrogen
,Cat#
T7459
JF635 HaloTag ligand,Lavis Lab,
Promega
Cat#
GA1120
D-biotin,J&K,Cat#
(13)
Efficient progranulin exit from the ER requires its interaction with prosaposin, a Surf4 cargo
The Journal of cell biology
February 7, 2022
Devireddy S, Ferguson SM.
h after prosaposin siRNA
transfection
,
HeLa cells
were treated with either DMSO control or
CB-5083
(
19311
;
Cayman Chemical
Co.) for 7 h before isolating protein lysates for
immunoblot
analysis. RUSH
live-cell imaging
(14)
Ubiquitination of G3BP1 mediates stress granule disassembly in a context-specific manner
Science (New York, N.Y.)
June 25, 2021
Gwon Y, Maxwell BA, Kolaitis RM, Zhang P, Kim HJ, Taylor JP.
mM, Millipore Sigma 1062771000), TAK-243 (1 μM, ChemieTek CT-M7243),
CB-5083
(1 μM,
Cayman Chemical
19311
),
bafilomycin A1
(10 nM,
Cayman Chemical
11038
), cycloheximide (100 μg/ml,
Sigma-Aldrich
C7698
), and
<<
<
>
>>
Reviews
Be the First to Write a Review!
CB-5083 from Cayman Chemical
Supplier Page
View Company Product Page
$267.00
Product Specs
Company Info
Citations
Reviews
Back To Top